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Fibroblasts cultured frotn lesional skin .in sclero-
derma (systetnic sclerosis) delnonstrate an activated 
phenotype that nlay be itnportant in pathogenesis. 
Endothelial cell-derived cytokines can tnodulate fi-
broblast properties, and endothelial cell changes oc-
cur early in sclcrodertna. Thus, cndothelial cell and 
fibroblast dysfunction tnay be linked through the 
paracrine activity of soluble endothelial cell prod-
ucts. We have explored endothelial cell-fibroblast 
interactions ill "itl'o by investigating the tnodulation 
of scleroderlna and control fibroblast properties by 
endothelial cell-conditioned tnediutn (EC-CM). 
EC-CM caused a concentration-dependent stitnula-
tion of fibroblast DNA and protein synthesis and 
upregulation of cell surface ICAM-l expression. 
Sclerodertna fibroblasts showed consistently greater 
responses than control cells. Mediutn conditioned by 
D:lechanically wounded endothelial cells had a 
T he pa.thogenesis of scleroderma (systen.lic sclerosis) is believed to itl volve abnorma li ties of the immune systel1l , vasculature. and cO llnective tissue that lead to excess ive extracellular man'Lx deposition in af-fected o rgans (Black. J 993). Altho ugh the specifIC 
n~echani sms underl yin g this process arc poorly und erstood , it has 
been suggested tha t an activated popu lation of fibrogel1ic fibro-
blasts is respo nsibl e (Mau ch "f (/ 1, 1993). T his concept is suppo rted 
by ill vi"<J studies dem onstra ting marke rs of fibroblast activation in 
early sclerod erma skin (Koch cl aI, J 993) and evidence of in creased 
c o llagen gene transcrip tion by ill sil" hybridiza tio n (Scharftetter eI 
aI, 1988). Sclero derma fibrob lasts cultured fi'o m lesional skin 
p ro du ce elevated amo ullts of coll agen (Le R.oy, J 974) and other 
conn ective tissue compone nts in cl uding proteoglycans and fi-
bronectin (Fleisch major 1'1 aI, 1981; Bucki ng ham cl aI, 1983) . It 
seenlS like ly. however, that th e pro perties of scleroderm'l (SS c) 
fibroblasts w ill have been modulated by external inAuences i" " jll", 
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greater effect than that from resting endothelial cells. 
Pre-incubation of EC-CM with anti-bFGF signifi-
cantly reduced the protnotion of fibroblast thytnidine 
incorporation but did not affect endothelial cell-
induced leucine incorporation. Conversely, anti-IL-l 
antibodies abrogated EC-CM-induced leucine incor-
poration and ICAM-l expression but did not ditninish 
thYlnidille incorporation. Recotnbinant bFGF or IL-l 
tnodulated fibroblast properties sitnilarly. These data 
dctnonstratc that endothclial cell-derived JL-l and 
bFGF tnodulate fibroblast properties independently 
and that lesiollal sclerodcrtna strains are nlore re-
sponsive than control fibroblasts to endotllelial ceIl-
induced modulation, which supports the hypothesis 
that altered endothelial cell-fibroblast conununica-
don Inay be involved in the pathogenesis of sclero-
dertna. Key 1V000ds: thylllidille/le "cill,e~fibl'os islelldotheli"lII. 
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and the regulato ry m echanisms il1\1 Ived arc likely to be relevant r.o 
the pathogenesis of fibrotic disorders. Extrinsic lIl od ulatio n of 
fibrob last properties ma y occur through direct comacr, such as 
lymphocyte-fib ro blas t interactions ,ria CD2- LFA3 and interce llular 
ad hesion m o lecul e 1 (I CA M-l )-LFA J (Smith and Kol'll, 1994), o r 
through the effec ts of va rio us paracrine mediators produ 'ed by 
ill1Jllun e cell s, e nd o th elial cells. o r activated fibrobbsts (LeRoy, 
1994). Fibroblast-matrix interactions ma)' a lso be impona n t, par-
ticu larl y in providing downregulatory signals to activated fibro-
blasts, and some studies have suggested that rh ese processes Illay be 
altered in scleroderma (Mau ch CI aI, 1992; TV:lnson ct nl , 1993). 
T he seq uential histo logic changes occurrin g wit.hin the skin in 
sc lero denn<l in clude: alte ration of the vasculature. activation of 
peri vascul ar fibrob lasts, and deposition of increased amounts of 
extracellular matrix (Presco tt el aI, 1992) . Endothelial ce Ll activa-
tion , however, appears to be one of the ea rl iest chan ges, of tell 
precedin g an )' other fea tures (Pearson. 1992) , and it has been 
proposed that vascular abn o rmali ties may be invo lved in activating 
fib ro bl;lsts in scleroderma (Ka haleh. 1990). T here is considera bl e 
evidence that endothelial cell products can 1110dublte fibrob last 
properties. and such intera cti o ns ha ve been studied in tissue cul ture 
system s empl oying difFeren t types of cell s (V illanu eva el nl , 1991; 
G uarda e( ai, 1993) . R ecently we reponed that scleroderma dermal 
fibroblast properties arc modu lated when co-cultured w ith a virall y 
transformed hUlllan end othelial cell lin e and th .1t they delllonstrate 
an altered pa tte rn of phenotypic mo dulatio n co mpared with co n tro l 
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fi bro bl asts ( D e n ton el til , 1 996) . Al th o ll g h s u c h a co-cul ture sys te m 
is a useful too l fo r d e m o n stra tin g t h e m o dula t io n o f o n e cell typ e by 
anoth e r , it h as lilTli ta ti o l1 s ill atte mptin g to ide nti fy the solubl e 
factors respon si b le fo r thi s m o dul ation . In t h e c urre n t study, we 
h ave extende d o ur wor k b y in vestigatin g th e e ftects of condi t io n ed 
m ed ia p r e pa red lI sin g Il o ntran s fo rm e d e arl y passage human ulllbil-
ic;d vein e nd oth e li 'l l cell s (HUVEC) o n sc le ro d e rma and co ntro l 
ji,bro bl as t pro p e r t ies and h ave d e fUled sp ecifi c endo theli a l cell 
pI'odu cts in vo lved . 
MATEJU ALS AND METH ODS 
F ibrobl as t C ultures Fibro bJ asts wcre grown fro m 4_mm3 punch skin 
biops ies taken fi'om les io nal skin of scle rodc ... ,," patients w ith acti ve di ffuse 
cutaneo us scle roderma and fro m no rmal hea lth )' CO ll tro l individuals. Biop-
sies were take n lei-om six scleroderma patients, all of w hom ful fi ll ed the 
American Coll ege of I~h cu l n a to l ogy prc lil11il1 a r~y dia g nostic c rite ria for this 
d isease ( 1980). Mean age (:tSEM) w as 40.5 ( :t 3.6) y, sex ra tio was SF: I. M , 
mea n d uratio n or scle roderma from the onset or the fi rst no n-R aynaud 's 
SYIIJptOlll was 3 i l (.:t 4) 111 0, and ITl c <]n duratio n o f R .. a ynaud 's phc ll o lll c n o n 
was 42 (:t 6) mo. Ave rage skill sclerosis sco re at the ti m e of skill bi opsy was 
3 1 ( :!: 3) ofa poss ible m ax imuL11 0[5 1 (13bc k, 1995) . Four o ffi vc contro l 
subjects werc fe l11ale, and mcan age fo r the control gro up was 41 .7 (:t 3.4) 
y. None or the subj ects was ta king co rti cos teroids o.r had received an ti-
fi bro ti c or imnlullosuppress ive therap y pri or to skin bio psy. Ethical approval 
for the skin bio psies was o bta ined fi'om the ll...oyal Free I-f ospi t,,, Ethi cal 
Practi ces Suh- o mmittee, and bio psies were taken wi th full in fo rmed 
consent. Fibroblasts were grown by standa rd explan t technique, each biopsy 
be ing fin e ly c ho pped using a sca lpel bladc, alld cultured in .I ulbecco's 
modified Eagles J11 ediuJ11 (DM EM) supple mell ted with J 0% feta l bovin c 
serul" . At conflu ence, 1l10 Ilo )"yc r s were rrypsillizcd and subcultured at n 
ratio of l :3. Fo r experiments, cell s were used betwccn the second and fift h 
passages. 
E ndothelial C ell Cultures H UVEC were cultured from fresh umbili cal 
cords using a 1lI0 dificati eJll of the l11 eth od o f Jafie .'1 nf (1 973). Ce ll s wCl'e 
ul tured in ta lldard culture medium (M 199/20'1'0 feta l bovine serum 
s UPpI CI111! lItc d with h e p a rill ilnd endotheli a l ce ll g ro w th sUp p ICl1lCm t) , and 
each cord gene rall y r idded tw u cO IIAu c llt 75-cm 2 culture Aasb at the 
second passage. T hese conAue llt endothe li al cei l cultures we re used to 
prepa rc c lldo th eLial cell-condi tio ned medium (.EC- C M). 
Preparation of Conditioned Medium Serum-free 'ondi tio ned I11 C-
di u ll l was used to ensu re tlw t scrUl1l o r growth fac to rs rr o lll endotheli al 
c ulture Ill Cdiutll di d no t con fo und o ur res ul ts. M Oll o la yc rs we re rinsed tw ice 
w ith se rum-free D M EM , and 10 1111 o f serum-frec DMEM we re added to 
the Aask. Condi tioning ti lll es between 0 and 20 h we re uscd . At the clld of 
the conditiOlli ng pc.-iod , Ill ed ium was aspirated and celltrifuged at 3000 X 
<~ for 10 m in . M edium was ei the r used illllllediatei y or stored at - 70· C . For 
sO lne cx pc rilll cnts para ll e l cultures we re lI sed to prepa re IIlCdiurn fro ln 
mechalli call ), wounded elldoth eli al cell mOllo layers. This method used a 
rubber po li cel11 all to detach endothe l; ,'] ce lls prio r to condi tionin g (Eguchi 
el fl f. '1992). lI y 4 h most o f the ce ll s had reatta ched to the tiss ue Culture 
plnstic . bur those rc nl ailling in suspensio n were rClllovcd b y centrifugation , 
as descri bed above. 
T h Ylnidine and Leucine Incorporation Incorporation o f radio labeled 
th Ylllidine alld le ucill ' was used as indi ces o f fi bro bl ast D NA and protein 
syn thes is, respectively. For these experimen ts dermal fib ro blas ts wer ' 
seeded ill 96-we ll cul ture pl ates at a density of 5000 cell s per we ll. Arte r 
cul tu re fo r 48 h in D MEM / I O'v., fe tal bovin e se rum , the medium was 
re placed b y se rum -fi'ee (0.5% bovin e senllll ,"bumin) DME M ror 2 4 h, at 
w hich lilll e test ll Jed iuII. was added (100 (.1.1 pcr we ll). Ex periments we re 
pe rfo rlll ed over '1 48-h pe ri o d in serlllll -free cO ll d ilio ns, ,md 1 (.I.C i 
radio labe led th ymid ill e W H]th ymidill e) o r leucine (('1-1 Jle ll ein e) per w ell 
was added du ring the filial 16 h of c ulture. Ac id-inso luble tri t iuJ11 incorpo-
rntio ll was de le rmill ed by precipita tio ll wi th 200 pJ of 5% tri chlo roaceti c 
acid fo llowed by was hing w ith m edlan o l alld so lubili zatio n ill 98% fonnic 
ac id . In co rporatio l1 \vas d c tc nn incd as rn c:ln di 'illtegratio ns pe r nlin fo r fi ve 
to tell replicate well s usi llg li q uid scill ti lla tio n coull tillg . 
E ffec t o [ EC- C M Oll F ibrobla.t C ell Number In parall e l expe rill. elllS. 
the eflect ofEC-CM ill cuba tio n on viable ce lllluJllbe r was de termill ed usillg 
the 3-(4 .5-dilll ethyll.hiazo l-2-yl)- 2,5-dipbell yl rcrrazo liulll bro m ide (MTT) 
ass,,), to nlcasure IlTitocho nd rial dc h ydrogcnas· activity. Il1 cubatio ns w ith 
serum-free EC-CM PI' 'pared as desc ribed above we re pe rfo rm cd 0 11 
replicate we ll s of a 96-well cul lure pl ate t11"t h"d been seeded "l a density 
of 5000 cell s per we ll. T he M TT assay was perfo rmed as d escl-ibed b y 
T HE JOU Il...NAL OF INVESTIGATIVE DER.MATOLOGY 
Mos lll ann ( 1983) by dete rminill g th e l1I ea ll abso rbance at 450 nm of three 
to six repli ca te \\'c ll s fo r each cul tu re t;o ndirjon . 
F ibroblast IC AM-l Expression ICA M- l was measured wi th a cell-
bOl1l1d enzym e- lin ked illlrJlllTl o,,"o rbc ll t assay tC'chni q ue (Pobcr ct III . 1986). 
Fibro bl asts we re seeded as desc ri bed ahovc, and test Ill cd ium Or c)' to kine 
wc re added fo r a 24-h incubation period . T he ce ll laye r was was hed three 
times in phosphatc-bnfl'ercd saline. fixe d fo r 20 rnin at 4· ill 0 .1 % 
glu t'lI:aldeh yde soJution . and thell washed th oro ughl ), with phusphate-
bufic rcd s"lin e. Th e enzYll1 e-linked inlJ'llun oso rbent assay was perfo rmed as 
fo ll ows: N onspec ilic prote in billding was blocked w ith 10";;, rat- (j'ce dried 
mil k so illtio n ro r I h , JI1urill' allli - huJl1 ;lJ'l ICA M- I antibod y w as added 
( I : I 000 dilu tio n) for I h. w ells were was hed fo r 30 min , and 'lnti - I AM -l 
an tibody bindin g was quan tified II sin g horse radish pe roxidase-conjugated 
goat anti - mo use IgG (J :2000) added fo r 'I h . T he enzym e-linked illll11U-
nosorbent assay was dcveloped by addi tio ll of O-phenyl diamillc dih),dro-
chlo ride/ H 2 0 2 solutio.ll and m easurement of mean absorbance at 450 nl11 
tl sing an ,l1HOIlWri c pla te re'lde r . T hree [0 six repli ca te we ll s wc re ll seci for 
c;lch tes t conditi o n ill at leas t three inde pendent eX pCril11cnts using d iffe ren t 
fibro bl as t and endothelial cell strains. 
Anti-cytokine Antibodies To in ves ti gate the ro le of in te rl cukin-l 
(IL- l) and b'lsic fi brob last growth ra cto r (bfGF) in endothelial ce ll- induced 
JI1 odula tio n o f fibroblast pro perties, EC-CM and appropriate contro ls 
incillding recombinant IL- l a (K &D Systems Ltd , Oxford , U .K..) were 
incllbated fo r 30 JIlin at rOOIl1 tcrnper;lture wi th ncu trali z ing a.lltibodies ro 
IL- I (a + (3) o r bFG F (Il...&D Systems Ltd). Antibodies were diluted in 
scnlln- ft'ee D M EM . Initi al experim ents CO llfirm ed their ability to ne utralize 
th e e flc t of recolnbinant cytokin cs at antibody cO ll centrati o ns b CQ.vccl1 to 
and 1000 ng per 1111 ;" concentration o r 500 ng per ml was subseqll c lltl y used 
fo r most incuba rio ll s. Colltro l stlldi es indicated that tlr ese antibodies had no 
eflect on basa l fI bro bla st Ic ucu.e or thymidine incorpo ratio n . 
Recombinant Cytokines Il...ecombillant hllJ1lan IL-l a (R &D) ,md b FGF 
(S igma C hemi ca l Co., St. Lo uis. M O) were liS cd in cO lIlTo l exper.ime llrs to 
comp" re tir e e ffects of these cy to kincs with t lr ose of EC- C M . Final 
cO llcentratio l1 s o fbFG.I' in serull1- fr ee mcdiulI1 were 10-500 ng per 1111 and 
fo r IL- 1(> 'we re 10-·1000 U per rnl. 
R ESU LT S 
Endothelial Cell-Conditioned Medium Promotes Fibroblast 
Protein and DNA Synthesis M edium condi t io n e d b y res tin g 
H U V EC pro m o te d DNA and pro te in syn t h es is in all of th e 
fibro blast strain s tes te d . T hj s e ftcct occurred after condi tionin g 
t imes as sho r t a s 2 hand in c re:lsed wi t h t h e dura tio n o f endo the li a l 
ce ll conditi o nin g. With undiluted conditi o n e d m e dium , maximum 
le u c in e in corpo ratio n fo r S Sc strain s was 17 0%, o f cha t o b taine d in 
the presen ce o f n o n c onciitioll ed rn edium , and maximum th ymidin e 
in corpo ratio n w as 3 40'% o f control. Fo r d e ta iJ e d chara c te ri z atio ll of 
th ese respo n ses , a co nditi o ning time o f 4- h was sele cted , because 
initial expe r im e nts sh o w e d that thi s inc ubatio n t im e g av e sig nifi-
call t a lld repro du c ible in c r eases . In a se ri es o f inde pende nt expe r-
im e nts, 4-h EC- C M caused con centra ti o n-de p e nde nt in c reases in 
both le u c in e and th ymidin e in corpo rati o n up to a maximuJl1 of 
1 65'}t" <l nd 25U%, resp ective ly (Fig 1) . M ean r esp o n ses fr O I11 inde -
p e nd e llt experim e n ts in w hic h SSc and colltro l fibrob last strains 
w e re tr e ated with undilute d EC-C M a re sh o wn in Fig 2 and w e re 
g rea te r fo r SSc strain s tha n fo r contro l fibro bla sts. alth o u g h this 
g re ate r respo n sivcn ess re ac h e d stati sti c al sig nifi can e o nl y fo r thy-
midine inc orpo rati o n (p = U.02 . S tud e n t's unpaire d t tes t). S imilar 
e ffe c ts o n t h ymidin e and le u c in e iJl corpo ration were observe d fo r 
fIbro blas ts tre ate d with recombinant bFGF o r IL- 1 CI, res pective ly. 
T hus, bFG F pro mote d S ' c fibro bl as t th ymidin e in corporation up to 
320% ba sa l a nd n o rmal d e rma l fibro b lasts (NDF) up to 2 U8% (Fig 
3) . Con verse ly, le u c ine in co rp o ra t io n was pro m o te d b y ]L-I CI with 
a thresh o ld con ccntrati o n of 1 UO U p c r 1111. T h e m e an ( :tSEM ) 
e ffect wa s small e r than th a t o bser ved fo r EC- C M : 1 2 1 (:t1 4-)% basa l 
fur SSc fibro blas ts and 11 '1 (±3)% fo r contro l strains ill three 
inde pe nde nt e xpe rim e nts with six diffe re nt strains; unlike th e e ffec t 
o f EC-CM . it did n o t re ac h sta ti stical sig nifi can ce (p = 0.07, paired 
S tnd e n t's t test. 
Wounded Endothelial Cells Release Increased Levels of 
Fibroblast StiJllulallts M echanical w o undin g o f the e ndo thdi al 
ce ll m o n o laye r pri o r to con ditio nin g a lte r ed th e patte rn o f m o du-
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Figure 1. Scleroderma fibroblast. protein alld DNA synthesis are prolTIoted b y EC-CM. S\!w m free medium (SFM) was conditioned fo r 0 to 20 b 
by confiuent 1110nolayers of H UVEC. In corporation of tririared (a) leucine and (b) th)'llIidilJc is ,,-"pressed as percent lIl ean disintegrations pCI' min for five 
replicate control (SFM) well s. For undiluted EC- M, maximullI enhancement occlII'red after 24 h conditioning (170 (± 2 \) for leuein\! and 320 (± 65) for 
rh y nlidinc) . For <1 fixed condj t io ll ing tlllll! of 4 11 , th e pro lll orio ll of b oth (c) le u c i.n e :'ll1d (rI) th Yl1lidill c ill c o rpo rati o n W:1S concentra tl o ll d e pe nden r :IS Sh OVVll 
in the lower pan els. Each data point repr'sellts mean (± SEM) for a se ri es of illdepcndcllt experiments using three to six SSc f,b roblast srrains. Bas:,1 
incorporation (dpl1l) was 5034 (± 807) and 442 1 (± 830) for thymidin e and leucine, respectivel),. 
lano n of fibro blast pro per ties, ~ I th o llgh this was onl y 'l pparenr for 
d iluted EC- C M . For co ncen tratio ns of 25 and 50"1(., the re was a 
sig niticantly g re ater promotio n al e ffect o n thymidine incOt:por<ltion 
as show n in Fig 4. Sim il ar data w ere obtain ed for leuc ine in corpo-
ra tion (not shown) sugges ti ng that rel ease of fu ctors m ed iatin g 
th ese effects was increased w hen the end o the lia l ce ll m o no layer was 
m echanica lly di srup ted prior to co ndition in g. 
IL-l and bFGF Arc Selective Mediators of Elldothelium-
Dependent Modulation of Fibroblast Phenotype T he pro-
motion of fi brob last le ucin e in corpol';lcion by undi lu ted EC-CM 
w a s inhibi ted b y pre-in cubation of th e m edium w ith ,1I1 ti-IL-
1 (a+ ,£3) antibody (Fig 5). Dose- respo nse curves (data not shown) 
indicated tha t an tibody con cen trati o ns of 500 ng per 1111 had a 
max imum effe ct, a ltho ugh som e inh.ibi tion was detected w ith l O n g 
per ml. T he e ll'C ·t of recombin ant IL- l a at a co ncentrati on of 100 
U per 1111 was abo li sh ed by pre-in cubatio n w ith anti-1L-1 at 500 n g 
per ml. Contro l d ermal fib ro hla st respon ses demonstrated a g reater 
inh ibition of EC-indu ced pro teiJl symh es is than did tll e SSc strains . 
The e ffe ct of un diluted EC-CM 0 11 thymidin e in co rpo ration "'as 
not red uced by antibo dies to IL- I but could be abrogated by 
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F igure 2 . E ndothelial cell induced promo tion of DNA and protein 
synthesis .is greater for sclcrodcrJ113 t han c ontrol dcrtllal fibro-
blasts . Scleroderma (SSe, II = 6) alld cO ll tl'ol (NO]: . n = 5) dcrmal 
fib ro blast srI'ains were in '"bared with se l'llll1-fi'ee EC- M alld til e iucorpo-
ratio n or tt ic-iated ( /I) leuc in e ;lI1d (b) th ynli dj n c ,vas CO lli pared \v irh rh :H of 
control cul ture we ll s cultured in rhe absence of E -CM. Each dara point 
rep r esents the ITlcan d isill fcgrario lls per I1lin fo r five n :p li catc well s. For 
thynl idinc ill 'o rponltio ll there was :l signi6c:mtl y grc:l tl'r response (p == 
0.02, ull pa ired Student's t test lo r SSe strains (206'% control) thall ror 
healt hy dermal fibroblasts ( 136%, contru l). T he Illean prolllooon of Iellcine 
in corpora rion by EC-CM was also greater fo r the SSc srrains ( \ 39%) 
compa red with healthy derlllal fibrob lasts ( 123' :1.,) , hut' this difference did IIOt 
reach sta tistica l Sig lli fi c:'1I1 CC . T he mean ( :!: SEM) t h ),111idill c inco rpo ratio n 
(dpm) in eolltrol (S FM) clli ture ' was 3985 (± 556) for SSe and 6675 
(_ 12 13) (or NOF. "nd for leucille incorpora tio ll wcre 9424 ( :!:: J 8 13) "lid 
42 16 (± 2754) , respectively. 
promoti o n was m ore comple te ly inhibi ted fo r contro l stra ins than 
fo r SSc fibroblasts (Fig 5). 
T he re W;IS low-level basa l express io n of! AM-l in bo th contro l 
and SS c fibrob lasts, but thi s was marked ly lIpregulated by cytokin es 
including tUlllo r necrosis fa ctor- a, interfc ro n-1' (data not sh o wn), 
or rL-l. T he m aximu l11 l C AM-\ express io n was not signifi cantly 
d.ifFe rent be twee ll SSc and control fib ro blasts. EC-CM also in-
creased l C AM-l eJ'press io n in all fibro blast strains tested (I' = 
0.005, paired Student's t test) , bu t w ith co nsistently g reater re-
spo nses for SSc stra i.ns (p = 0 .04). EC- M prepared fro m woun ded 
EC 1l10uolayers was marked ly Ill o re po ten t than from resting 
endothe li al ce ll s. Pre-in cubatio n of EC- e M with an tibodies [Q 
LL-1 (a + f3) at 500 ng pe r Ill! b locked upregulation of lCAM-l 
express ion (I' = 0.01, pajred Studen t's t test. F ig 6). 
T he e ffects descri.bed above do not reRect inc reased fibm blast 
nUlnlJe r fo llowing iJlcubati on with EC- M, because data fi 'o l11 
M TT ass"ys perform ed o n para Ll e l p);l tes showed no sig llifi ctll1t 
chan ges be rween Ilo ncondi tio ned m ediulll an d condi tioned m e-
di ulII fi'o m e ither resting o r dam aged endothe lial cells (Table I) . 
For co mparison , vi:lb le cell numbers inc reased in w e ll s cul tu red 
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Figure 3. Stimulation o f scleroderma fibrobla st DNA synth esis is 
greater than control fibrobl ast strains in response to recolubillllnt 
bFGF. Mea n data fo r three iudcpclldell( experilllents II sing three SSc and 
three NDF straills. Mean (+ SEM) basal incorporation in SFM ",t,s 6248 
(+ 2 162) for S C "lid 10,31:18 ( 6,tl I9) 01'111 for NOF slleains. * indicates p 
0.05 , unpaired Student's t test. 
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F igure 4_ Mechani cal wounding of endothelial cell monolayer 
enhances the effect of conditioned medium on fibroblast DNA 
synth esis. Promotion of thymidine incorporation by SSc fibrob last strain s 
was different fo r medium conditioned for 4 h with resting HUVEC 
compared with medium condi tioned by EC monolayers that had been 
mechanica ll )' di srupted (sec Mnterinls nllli Methods). Data points show the 
mean (:t SEM) for three to six independent experiments using different SSe 
and H UVEC stra ills . Mean (:t SEM) control serUIll free medium (SFM) 
incorporation was 50 '1 8 :':: 796 dplll (= '100%,). Analysis by Student's paired 
t test, " p < 0.05, damaged IIerSllS resting EC-CM. 
medium . T he resu lts hown were o btain ed for SSc fibrobl ast 
strain s; equ ivalent data (not shown) were o btained fo r NDF. 
DISCU SS ION 
Fun ction al interactio ns be tween endothelial cell s and fibroblasts 
m ay be impo rtan t in wound h ea ling, atherogenesis, and post-
an gioplasty restenosis (McNeil ef a/, 1989; Villan ueva ct a/, 1991). 
T here is considerable ex perim en ta l evidence to support this, and 
many ca ndidate m ediators have been proposed , in clud in g bFGF 
(Sch weigerer ef a/, 1987), TGFf3 (Anto nell i-Orlidge el a/ 1989), 
pl atelet-derived growth facto r (PDGF) (Di cOl'leto and Bowen-
Pope, 1983), endothe lin-l (ET-1) (Wagner el a/ , 1992) , and 
conn ective tissue growth factor (Igarashi cl ai, 1995, 1.996) . T hese 
factors arc synthesized by endoth eli al ce lls ill lIilm, and a ll are 
capable of m odul atin g fibrob last pro li fe ra t ion and extracellular 
matrix synthesis and secretion. In scleroderma, studies have sug-
gested a ro le for endothelial cell-derived fibrogenic substan ces 
including ET-1 (Kahaleh, 1.991). W e, the refore, set up a co-culture 
system to exa min e th e modu latory inte ractio ns of endo thelial ceUs 
Figure 5_ IL-l and bFGF in EC-CM induce enhanced 
fibroblast prote in and DNA synthesis, respectively . 
Promotion of leucin" incorporation (n) was reduced by a 
mixture of neutrali zing antibodies (500 ng per ml) aga inst 
[L-1 a alld tL-1 {3, but was not altered by antibody to bFGF. 
In contrast, anti-bFGF (SOD ng per ml) inhibi ted the eflect 
orEC-CM on thym idi,w incorporation (b) for both SSe and 
norm:'/ dermal fibrob last strains, whereas anti- I L1 (a + (3) 
had no ellect. Res ul ts arc mean (:tSEM) pcrc"nt contro l 
culture disintegrations per min for independent experi-
ments using five SSe and fo ur NDF strains. Analysis by 
Student's paired t test, * indicates significantly (p < O.OS) 
above serum free control; t indica tes significa ntl y (p < 
0.(5) below BC-CM and not significa lltl y diU'erent ITom 
serum fi'"e contro l. Mean (::': SEM) in corporation (dpm) fo r 
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and fibrob lasts (Denton el a/1 996) and dem o nstrated that fibroblast 
cell number, proli feration rate, and coll agen secretion were aU 
significantly a ltered in co-culture with the virally transformed 
human endothelial ce ll lin e 1 E- 7 (Fickling ct ai, 1992) . M o reover, 
we observed greater changes in scle roderma fibroblast stra.ins than 
in m atched normal contro l cells. T h e current experim ents extend 
these findings by using cady passage primal'Y HUVEC cul tures and 
identifying two of the important transferab le m ediato rs tha t affec t 
fib ro blast p henotype. W e confirm ed that scl e ro derma fibrobla sts 
are m o re responsive to en dothelial cell-derived factors and that 
endothelial cell-derived IL-1 selectively enhanced prote in synthe-
SIS, whel'eas endotheli al cell-derived bFGF selective ly en hanced 
DNA synth esis. 
Endothe li al cell-de rived IL-1 has been shown to induce rL-6 
secretion .and upregula te endothe li al ce ll adhesion molecule expres-
sion (DeJana and Mantovani , 1989). R ecent studies also suggest 
that anti-endothelia l cell autoan tibodies fi'om scleroderma patients 
s~rum promote ad hes ion m o lecul e ex pressio n a.nd leukocyte adhe-
sIo n through the I'elease and loca l efFects of IL -J (Carvalho el ai, 
1996). IL-1 is implicated in scleroderma pathogenesis; for example, 
upregul ation of IL-l receptors has been reported in scleroderm a 
fibrob lasts and correlated with in creased ill "ilm responsiven ess to 
exogenous IL-lf3 (Kawaguchi el ai , 1993 ). Scleroderma fibrob lasts 
~la ve also been shown to overproduce IL-1 (Kawaguch.i , 1994), and 
It has recen tl y been suggested that th ere may be intracrine 1L-1 
pathways in scl e rod erma fibroblasts. ' O ur own results show that 
endoth ~ li a l cell-derived IL-1 in creases fibrob last tota l protein 
syn theSIS under conditi ons in which cell number does not change, 
Le ucin e is present in most cellul ar proteins, typicaUy comprisin g 
about 8
'
y" of amino acid res idues. T hi s ubiquity makes radiolabeled 
leucin e incol'poration a good index of tota l intra cellular proteiJ1 
synth esis in tissue culture. It is o nl y a minor amino ac id constituent 
?f som e impo rtan t extracellular matrix proteins, however, includ-
Illg the colla gens , and furth e r: stud ies w ill be necessary to determine 
whether in creased protein syn thesis induced by endothelial cell-
deri ved IL-l is associated w ith enhan ced re lease of extracellular 
matrix components. 
In creased levels of ce ll surfa ce l CAM-1 expressed by sclero-
derm a fibrob lasts (Abraham cl ai, 1991) appear to m edi ate increased 
lymphocyte-fibrob last binding ill "ilm (Smith and Korn, 1994). Our 
data confirm those of prev io us studi es showing that pro-inflamma-
to ry cytokin es upregula te fibroblast l CAM-l express ion (Cho cl ai, 
1994; Shi- wen cl ai, 1994), and demonstrate that IL-1 is the active 
constituent of EC-CM mediatin g the upregulation of 1CAM-1. 
.Basic fibrobla st gro wth factor (bFGF) is one of th e most potent 
mltogens rel eased fi'om endothelial cells. It is inte resting that 
EC-CM was mitogen ic even afte r brief condi tioning. T his is 
somewhat surprising, beca use bFGF lacks the leader peptide se-
quen ce genera Ll y necessary fo r secretion and therefore might 
'Kawaguchi Y and W right TM: IL-1a d"Wrm ines th" fib rogenic 
phenotype of systemic schlerosis fi brob lasts. A rthritis 1<1"'1/11/ 39:S315, 1996 
(abstr). 
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require endotheLial cell damage to ca use its release (Mignatti and 
Rifkin , 1991), as has been the case in o the r repo rted stud ies (Eguchi 
et aI, 1992). T he clIect seen in scleroderma fibrobl asts may refl ect 
e nhanced sensiti vity to bFGF's mitogenic effects. When m echani-
ca lly damaged endoth elial cell s were used to prepare the EC- C M , 
a greater stimulato ry e ffect o n thymidine incorporation than resting 
EC- CM was observed only with diluted conditioned medium , 
suggesting that eith er hi gh concen tratio ns of bFGF (as in Fig 3), or 
perhaps other endothelial ce ll products may have a detrimental 
e ffect. 
Scleroderma fibmb lasts are less dependent upon se rum supple-
men tation in cul ture than are control fibroblasts (LeRoy el a/, 
1982), although the ir pro lifera tion rates in conven tional cultures 
appear similar to those of contro l cells. In contrast, scleroderma 
strains are more sensitive than control fibrob lasts to the effects of 
serum on the rate of biosynthesis of collagen and other matrix 
components (Bashey and Jimenez, 1977). T his emphasizes the 
disparity between varioll s scleroderma fibroblast phenotypes. Many 
studies have reported redu ced mitogenic responsiveness to exoge-
nous cytokines, including epidermal growth ta ctor, PDGF, and 
ET-l (LeRoy e/ a/, 1982; Takehara e/ a/, 1991). It is no table, 
therefore , that we ha ve measured consistcntly greater responses to 
E C - C M in sclero derma strains. T hi s may reflect otlter factors in 
Ee- CM or m ay indicate that a com bination of cytokines ha s a 
markedly different effect fi'om single facto rs, esp ecia.lly 011 an 
activated cell population. T his interplay between cytokines in 
mediating proliferation has been demonstrated clearly t'Or PDGF 
and TGFJ3 (Yamakage e/ a/, 1992). Hitherto, there h ave b een few 
direct studies of the role of bFGF in scleroderma pathoge nesis, 
although comparative studies with PDGF sugges t that scleroderma 
Table I. Scleroderma Fibroblast CelJ Number Is Not 
blcreased by Serum-Free EC-CM" 
MTT activity C'X, SFM cO ll tl'o l") 
SFM' EC- C M" EC W-CM" PBS" 
Mean 100 102 1 04 134 
SEM 12 12 16 16 
[ test NS NS P < 0.02 
II Mean ci;Ha for six indcpcndcnr experiment's usin g d i(fe rc lll EC and SSe fi broblast 
strain s: paired Studellt's (test cOl1lp 'lring t CS l conditions with SFM. 
b Mean absorba" ce lor SFM colltrol = 0.32 (± 0.02) . 
~ SEM , serum frec cu lture med ium. 
(/ EC-CM. m edium cOl1ditiol1 ~d f'Or -I II w ith 1I1lsti mul iltcd cndothdial ce ll s. 
,. E C W-C M , medium coudi tioned for 4 11 with I1lcchani t:a ll y damaged endothelia l 
cells. 
. f FBS . cul rure medium supplemented with 1 O%~ fetal bo vine Serulll . 
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Figure 6. IL-l in EC- CM enhances fibroblast 
ICAM-t expression . Expression of ICAM-l was q uanti-
fi ed by abso rbance at 450 nm w ith a cell-bound enzym e-
linked il11l1lunoso rbent assay . The effect of incubation for 
24 h with co ndi tioned media pre pared from resting (EC-R) 
o r mechanically wounded (EC- \V) endo thelial monolay-
ers, and of recombinant lL-'1 a, on ICAM-l expression 
were compared . Neutralizing antibodies to lL-l a+f3 (500 
ng pCI' ml) we re used to block the effects of recombinant 
and EC-deri ved IL-l, Results are mean ( :!: SEM) absor-
bance for replicate well s in three independent experime nt.' 
employing d ifferent fib roblast stra ins and EC cultures. 
An,lI ysis by Studen t 's paired t test. • indicates significantl y 
(I' < 0.05) above serum free co ntro l; t indicates signi fi -
cantly (I' < 0.05) be low EC-C M. 
fibroblasts do not upregu l ~te bFGF receptors to the sam e extent as 
PDGF receptors in response to TGF{3 (Kikuchi el a/, 1992). 
In additio n to I.L-1 and bFGF, other endothelia.! ce ll products 
may m odula te fibroblast protein or DNA metabolism . T his i 
consistent with tile observation tha t it was not possible to inhibit 
completely EC- C M-induced DNA and protein synthesis even w ith 
a high concen tration of bl ocking antibody, a fi nding most clearly 
dem onstrated in the scleroderma strains . Potential candidates in-
clude the numerous cytokines that have been shown to be re leased 
by EC ill "ill'O including PDGF, connecti ve tissue growth factor, 
IL-6 , and IL-8 (Swed ick and Lawley, 1993). Altho ugh ET-1 migh t 
be a candida te, o ur own studies suggest tha t the ET receptor 
antagonist bosentan (Ro 47-0203) (Glozel el aI , 1994) does not 
inhibit the effects of EC-CM .2 Mechanical wounding has been 
shown to increase th e release of both IL-1 and bFGF (.Eguchi CI a/ , 
'1992) , and this is consi stcnt with our fi ndings. 
In conclusion, we have demonstra t.ed that sclerodcrma fibro-
blasts are particularly sensitive to endothelial cell-induced pheno-
typic m odulation , consistent with the concept that tllese ells 
represen t an activated fibroblast populatio n . We have confirmed, 
using neutralizing antibodies and purified cytokines, that mediators 
of th.is mo dulation include lL-l and bFGF and that damaging tile 
endothelial cell m ono layer alters fibroblast responses. Ca utio n is 
esse ntial in ext.rapola ting these findin gs to disease events i ll lIil'(), 
in asmuch as o ur system uses macrovascu lar fetal endotheli al cells , 
and pathogenic changes in scleroderma OCCUT within tbe adult 
microvascular bed. Scleroderma dermal microvascular endothelial 
cell s h ;lve reccntly b een isolated (Kraling c/ (//, :I 994), and prelim-
inary in vestigation showed no maj or difference from contro l dermal 
microvascular cell s. Future studies of the soluble products fi'om 
these cells may sh ed further light on endothelial cell-fibro bla st 
interactions in scleroderma. N everth eless , our data provide further 
evidence for flln ctional interaction between endothelial cells and 
fibrob lasts, which is like ly to be relevant for the regu lation of both 
types of cells ill " il) l) . 
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